Human Papillomavirus (HPV) related oropharyngeal squamous cell carcinomas (OPSCCs)
are reported to have improved prognosis and survival in comparison to other head and neck …

Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and
neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most …

Context Human papillomavirus (HPV) is a major cause of oropharyngeal squamous cell
carcinomas, and HPV (and/or surrogate marker p16) status has emerged as a prognostic …

Purpose: Despite generally favorable outcomes, 15% to 25% of patients with human
papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma (OPSCC) will have …

BACKGROUND There has been increasing interest in the primary surgical treatment of
patients with early T classification (T1‐T2) oropharyngeal squamous cell carcinoma …

Objective Human papillomavirus-positive (HPV+) head and neck squamous cell carcinoma
is increasing in incidence and appears to exhibit improved response to treatment and better …

Background Patients with oropharyngeal squamous cell carcinoma (OPSCC) have been
shown to have distinct outcome profiles based on their human papillomavirus (HPV) status …

In the recent years, the prevalence of HPV-positive oropharyngeal squamous cell carcinoma
(OPSCC) has increased significantly. Currently, nearly 80-90% of all oropharynx tumors are …

Recent next-generation sequencing studies have generated a comprehensive overview of
the genomic landscape of human papillomavirus (HPV)–associated cancers. This review …

Objectives: To review evidence for the role of human papillomavirus (HPV) in the etiology of
oropharyngeal cancers, methods of viral detection, and the resulting clinical implications …